Keragala CB - Search Results

1

Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach.

Liu Z, McCutcheon FM, Ho H, Chia J, Xiao Y, Tippett I, Keragala CB, Cloud GC, Medcalf RL. Liu Z, et al. Among authors: keragala cb. Res Pract Thromb Haemost. 2023 Aug 9;7(6):102166. doi: 10.1016/j.rpth.2023.102166. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37694270 Free PMC article.

2

Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.

Draxler DF, Daglas M, Fernando A, Hanafi G, McCutcheon F, Ho H, Galle A, Gregory J, Larsson P, Keragala C, Wright DK, Tavancheh E, Au AE, Niego B, Wilson K, Plebanski M, Sashindranath M, Medcalf RL. Draxler DF, et al. J Thromb Haemost. 2019 Dec;17(12):2174-2187. doi: 10.1111/jth.14603. Epub 2019 Sep 3. J Thromb Haemost. 2019. PMID: 31393041 Free article.

3

Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target?

Mutimer CA, Keragala CB, Markus HS, Werring DJ, Cloud GC, Medcalf RL. Mutimer CA, et al. Among authors: keragala cb. Stroke. 2021 Aug;52(8):2707-2714. doi: 10.1161/STROKEAHA.120.033107. Epub 2021 Jun 15. Stroke. 2021. PMID: 34126761 Review.

4

Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery.

Draxler DF, Hanafi G, Zahra S, McCutcheon F, Ho H, Keragala CB, Liu Z, Daly D, Painter T, Wallace S, Plebanski M, Myles PS, Medcalf RL. Draxler DF, et al. Among authors: keragala cb. Thromb J. 2022 Apr 11;20(1):17. doi: 10.1186/s12959-022-00373-3. Thromb J. 2022. PMID: 35410340 Free PMC article.

5

Tranexamic acid for haemostasis and beyond: does dose matter?

Lam T, Medcalf RL, Cloud GC, Myles PS, Keragala CB. Lam T, et al. Among authors: keragala cb. Thromb J. 2023 Sep 12;21(1):94. doi: 10.1186/s12959-023-00540-0. Thromb J. 2023. PMID: 37700271 Free PMC article. Review.

6

t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke.

Draxler DF, Lee F, Ho H, Keragala CB, Medcalf RL, Niego B. Draxler DF, et al. Among authors: keragala cb. Front Immunol. 2019 Mar 27;10:591. doi: 10.3389/fimmu.2019.00591. eCollection 2019. Front Immunol. 2019. PMID: 30972077 Free PMC article.

7

Tranexamic Acid Influences the Immune Response, but not Bacterial Clearance in a Model of Post-Traumatic Brain Injury Pneumonia.

Draxler DF, Awad MM, Hanafi G, Daglas M, Ho H, Keragala C, Galle A, Roquilly A, Lyras D, Sashindranath M, Medcalf RL. Draxler DF, et al. J Neurotrauma. 2019 Dec 1;36(23):3297-3308. doi: 10.1089/neu.2018.6030. Epub 2019 Aug 2. J Neurotrauma. 2019. PMID: 31140372

8

Fibrinolysis and COVID-19: A plasmin paradox.

Medcalf RL, Keragala CB, Myles PS. Medcalf RL, et al. Among authors: keragala cb. J Thromb Haemost. 2020 Sep;18(9):2118-2122. doi: 10.1111/jth.14960. Epub 2020 Jul 15. J Thromb Haemost. 2020. PMID: 32543119 Free PMC article.

9

Fibrinolysis and COVID-19: A tale of two sites?

Keragala CB, Medcalf RL, Myles PS. Keragala CB, et al. J Thromb Haemost. 2020 Sep;18(9):2430-2432. doi: 10.1111/jth.15017. J Thromb Haemost. 2020. PMID: 32692877 Free PMC article. No abstract available.

10

Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement.

Keragala CB, Woodruff TM, Liu Z, Niego B, Ho H, McQuilten Z, Medcalf RL. Keragala CB, et al. Front Neurol. 2020 Dec 8;11:577272. doi: 10.3389/fneur.2020.577272. eCollection 2020. Front Neurol. 2020. PMID: 33363504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page